Jeffrey W. Albers
2 stock trades in the last 12 months, shares they bought or sold themselves (not grants or options).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Every trade Jeffrey W. Albers reported
| Stock | Trade | Amount | Traded |
|---|---|---|---|
| Sell(10b5-1 plan) | $2.4M | Aug 7SEC filing | |
| Sell(10b5-1 plan) | $449K | Dec 8, 2025SEC filing |
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Jeffrey W. Albers' companies
| Stock | Trades | Quality Score |
|---|---|---|
| 1 | ||
| 1 |
Alerts for Jeffrey W. Albers
Use this page
How to cite
Breakaway, Jeffrey W. Albers: Director at Spyre Therapeutics (SYRE), Aug 10, 2026, getbreakaway.com/insiders/jeffrey-w-albers
Journalists: email support@getbreakaway.com for the data behind this page.